Evidence map›Paper›PMID 42147607›Full record

ArticleCureus2026

Renal and Splenic Infarctions: Unmasking Rheumatic Mitral Valve Disease in a Young Adult.

Esperance M Madera, Elda Mullaj, Anish Munagala, Priyanka Bhargat, Joseph Trifari

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Esperance M MaderaInternal Medicine, Mount Sinai Hospital, Chicago, USA.
Elda MullajCardiology, Mount Sinai Hospital, Chicago, USA.
Anish MunagalaCardiology, Mount Sinai Hospital, Chicago, USA.
Priyanka BhargatInternal Medicine, Detroit Medical Center, Wayne State University School of Medicine, Michigan, USA.
Joseph TrifariInternal Medicine, St. George's University School of Medicine, True Blue, GRD.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic thromboembolism is an uncommon but clinically significant complication of rheumatic heart disease (RHD), most often seen in association with infective endocarditis. We describe a 39-year-old woman with no known cardiovascular comorbidities who presented with acute left-sided abdominal pain. Imaging revealed concurrent renal and splenic infarctions. Further evaluation uncovered paroxysmal atrial fibrillation, severe mitral regurgitation, and moderate to severe mitral stenosis with marked left atrial enlargement. Transthoracic and transesophageal echocardiography confirmed the diagnosis. She was managed with anticoagulation, rate control, and subsequently underwent surgical intervention consisting of mitral valve replacement, tricuspid annuloplasty, and left atrial appendage closure. Postoperatively, the patient had an uneventful recovery, with stable vital signs, no evidence of thromboembolic events, and sustained sinus rhythm at discharge. Repeat echocardiography showed a well-seated and normally functioning mitral bioprosthesis, with no rocking motion and no significant trans-prosthetic or peri-prosthetic regurgitation. This case highlights the importance of considering RHD as a potential cause of systemic embolism, even in younger patients without traditional cardiovascular risk factors. It emphasizes the need for a thorough cardiovascular evaluation in patients presenting with systemic embolism to ensure early diagnosis and appropriate management.

Indexed as

atrial fibrillationmitral regurgitation (mr)renal cortical infarctrheumatic valvular heart diseasesplenic infarct

Identifiers

PMID42147607
PMCPMC13179819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.